Effectiveness of Dapagliflozin for Weight Loss

Clinical trial NCT03968224 · COMPLETED

Trial details

NCT number: NCT03968224
Sponsor: Centro Medico Nacional Siglo XXI IMSS
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

PreDiabetes Obesity, Morbid Diabetes Mellitus, Type 2

Start date: 2018-08-04
Primary completion: 2024-07-31
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.